RPRX fund manager activity
Royalty Pharma plc · Nasdaq. Reported by 6 tracked fund managers in their 13F filings, Q2 2020 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Pat Dorsey - Dorsey Asset Management | Trimmed | 2,259,469 | $87,305,882 | 7.59% | Feb 17, 2026 |
| Samantha McLemore - Patient Capital Management | Added | 3,333,675 | $128,813,194 | 4.97% | Feb 13, 2026 |
| Torray Funds | Added | 744,355 | $28,761,889 | 4.12% | Jan 28, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Pat Dorsey - Dorsey Asset Management | New | 2,350,449 | $82,923,841 | 7.45% | Nov 14, 2025 |
| Samantha McLemore - Patient Capital Management | Added | 3,117,850 | $109,997,741 | 4.40% | Oct 30, 2025 |
| Torray Funds | Added | 702,883 | $24,797,712 | 3.36% | Oct 22, 2025 |
| Viking Global Investors | Sold out | — | — | 0.00% | Nov 14, 2025 |
Newer quarters · Older quarters